Ausejo, Ayesha Kendra E.
HRN: 26-44-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2026
03/26/2026
IV
750mg
Q6
PCAP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines